Following our previous post here, we provide an update on the current developments in this area. On April 2, 2025, the US administration announced reciprocal tariffs on all imports into the United States (see here). As it has been widely reported, pharmaceutical products were exempted from these tariffs whereas medical devices were not. Subsequently, on April 9, 2025, the administration announced a 90-day postponement of the reciprocal tariffs for most countries except for China. For…
To date, Canada has implemented three rounds of retaliatory tariffs at a rate of 25% against certain US origin goods, with a fourth round…
In a context of increasing trade barriers to Brazilian exports, especially the additional tariffs imposed by the United States (US Reciprocal Tariffs) that include…
On 14 April 2025, the European Commission accepted Implementing Regulation (EU) 2025/778 (link), which lays down (additional) retaliatory measures to counter balance those imposed…